- Home
- THFF vs ABSI Comparison
THFF vs ABSI Comparison
Compare THFF & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | THFF | ABSI |
|---|---|---|
| Founded | 1984 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 948.0M | 997.8M |
| IPO Year | 1995 | 2021 |
Fundamental Metrics
Financial Performance| Metric | THFF | ABSI |
|---|---|---|
| Price | $80.25 | $7.59 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 4 |
| Target Price | ★ $62.00 | $6.96 |
| AVG Volume (30 Days) | 91.1K | ★ 3.8M |
| Earning Date | 04-28-2026 | 05-07-2026 |
| Dividend Yield | ★ 3.46% | N/A |
| EPS Growth | ★ 67.00 | 10.64 |
| EPS | ★ 1.67 | N/A |
| Revenue | N/A | ★ $4,534,000.00 |
| Revenue This Year | $17.88 | $215.96 |
| Revenue Next Year | $4.03 | $319.10 |
| P/E Ratio | $48.54 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $51.21 | $2.24 |
| 52 Week High | $82.03 | $12.06 |
Technical Indicators
Market Signals| Indicator | THFF | ABSI |
|---|---|---|
| Relative Strength Index (RSI) | 66.70 | 41.93 |
| Support Level | $74.09 | $2.56 |
| Resistance Level | N/A | $12.06 |
| Average True Range (ATR) | 1.92 | 0.66 |
| MACD | 0.30 | -0.29 |
| Stochastic Oscillator | 82.02 | 24.24 |
Price Performance
Historical ComparisonAbout THFF First Financial Corporation Indiana
First Financial Corp operates as a financial holding company, which is engaged in the provision of financial services in the United States. The company offers a wide variety of financial services including commercial, mortgage, and consumer lending, lease financing, trust account services, depositor services and insurance services, through its subsidiaries. Its primary source of revenue is derived from loans to customers and investment activities. Company's loan portfolio was diversified in Commercial, Residential and consumer domains.
About ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process. Its lead product candidate, ABS-201, is an anti-prolactin receptor (PRLR) antibody engineered with an extended half-life to support a patient-friendly dosing interval.